Clinical Trial Update: Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ubiquinol for heart failure with preserved ejection fraction (HFpEF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Ubiquinol (ubiquinol)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Heart Failure | Phase 2 | Status: UNKNOWN